ME - Prakiraan volume dodolan 23andMe Inc

Logo grafis 23andMe Holding Co (ME)

The stability of 23andMe Holding Co. (ME) is driven by the robotization of genetic testing, a trend confirmed by the company's sales volume on GURU.Markets, where the 0.21 level serves as a critical benchmark. The financial foundation relies on subscriptions and the sale of tests during a business model transition. Simultaneously, the brand is overcoming a crisis of confidence by reshaping its image into a full-fledged clinic for data protection.

Volume dodolan mangsa ngarep perusahaan: 23andMe Inc (ME) kanggo 04.07.2022 - 05.04.2025

Rincian metrik keuangan lan pasar 23andMe Inc. (ME)

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental:ME 23andMe Inc
Sampel barang 23andMe Holding Co

Investors are assessing the business resilience of 23andMe Holding Co. (ME) through the stability of its cash flows. The indicator calculates a daily revenue forecast, filtering out random market volatility to identify real growth potential. By analyzing the trajectory of the company's future sales, one can determine whether there is a margin of safety or a stagnation of drivers. This is critical for 23andMe Holding Co. (ME), as demand for genetic tests is declining. A decrease in this metric confirms the inefficiency of the subscription model and the risk of capital depletion.

Pesaing 23andMe Holding Co. (ME)

Prakiraan pendapatan perusahaan Agilent (A)|Prakiraan volume dodolan Quest Diagnostics Incorporated (DGX)|Prakiraan pendapatan perusahaan Illumina Corp ILMN|EXAS: Prakiraan pendapatan perusahaan|RVTY: Volume dodolan mangsa ngarep perusahaan|Prakiraan dodolan perusahaan bio-rad.com (BIO)|NNNN: Prakiraan volume dodolan|Sotera Health - Pendapatan mangsa ngarep perusahaan|QDEL (quidel.com) - Prakiraan volume dodolan|OPK: Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan CDNA (CareDx)|Prakiraan volume dodolan Maravai LifeSciences (MRVI)|Fulgent Genetics, Inc. - Volume dodolan mangsa ngarep perusahaan|LAB: Prakiraan pendapatan perusahaan|Cytek Corp - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan OSUR (OraSure Technologies)|XGN: Prakiraan volume dodolan|MDxHealth - Pendapatan mangsa ngarep perusahaan|LUCD (luciddx.com) - Prakiraan volume dodolan|PRE - Prakiraan dodolan perusahaan|Prakiraan pendapatan perusahaan Insight Molecular Diagnostics Inc (IMDX)|TRIB - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan PRPH (ProPhase Labs, Inc.)|Dodolan mangsa ngarep perusahaan ainos.com (AIMD)|Co-Diagnostics Inc - Prakiraan volume dodolan|HSCS - Prakiraan volume dodolan|BMRA (Biomerica Inc) - Volume dodolan mangsa ngarep perusahaan|CDIO - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Onconetix Inc|VRAX - Prakiraan dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan BJDX (Bluejay Diagnostics)|Prakiraan volume dodolan Aspira Women's Health, Inc. (AWH)|Prakiraan pendapatan perusahaan acceleratediagnostics.com AXDX|Prakiraan volume pendapatan perusahaan CNTG (centogene.com)|ENZ - Prakiraan pendapatan perusahaan|FRES - Prakiraan volume dodolan|GENE: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan PMD